Drugs A-Z Is my price fair? Price changes Drug markups Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Updated daily

Drug recalls

Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.

Class IICompletedAug 30, 2023AstrinGynCGMP Deviations: Products not manufactured under current good manufacturing practices.Ecometics, Inc. · D-1101-2023Class IICompletedAug 30, 2023activator concentrateCGMP Deviations: Products not manufactured under current good manufacturing practices.Ecometics, Inc. · D-1100-2023Class IICompletedAug 30, 2023Unguentine OintmentCGMP Deviations: Products not manufactured under current good manufacturing practices.Ecometics, Inc. · D-1099-2023Class IICompletedAug 30, 2023ALCOLADO RELAMPAGOCGMP Deviations: Products not manufactured under current good manufacturing practices.Ecometics, Inc. · D-1098-2023Class IICompletedAug 30, 2023YAGER'S LINIMENTCGMP Deviations: Products not manufactured under current good manufacturing practices.Ecometics, Inc. · D-1097-2023Class IICompletedAug 30, 2023Blis-To-Sol LiquidCGMP Deviations: Products not manufactured under current good manufacturing practices.Ecometics, Inc. · D-1096-2023Class IIIOngoingAug 30, 2023Trandolapril and Verapamil Hydrochloride Extended-Release Tablets 2 mg / 180 mgSubpotent: Out of Specification for Assay Test at the 3-month time point.Glenmark Pharmaceuticals Inc., USA · D-1095-2023Class IIITerminatedAug 30, 2023Moxifloxacin - Bromfenac Sterile Ophthalmic Solution 0.5% / 0.075%Subpotent Drug; sub-potent Bromfenac levels, below the 90.0-110.0% specification range.Imprimis NJOF, LLC · D-1094-2023Class IITerminatedAug 30, 2023Helix CBD Clinical CreamCGMP DeviationsParker Laboratories, Inc. · D-1093-2023Class IITerminatedAug 30, 2023Helix CBD Therapy CreamCGMP DeviationsParker Laboratories, Inc. · D-1092-2023Class IITerminatedAug 30, 2023Helix Tri-Active Therapy CreamCGMP DeviationsParker Laboratories, Inc. · D-1091-2023Class IITerminatedAug 30, 2023Helix Pain Relieving CreamCGMP DeviationsParker Laboratories, Inc. · D-1090-2023Class IITerminatedAug 30, 2023Protex Foaming Hand SanitizerCGMP DeviationsParker Laboratories, Inc. · D-1089-2023Class IITerminatedAug 30, 2023Rufinamide TabletscGMP deviations: Batch was released prior to approval.Aurobindo Pharma USA Inc. · D-1088-2023Class IITerminatedAug 30, 2023Rufinamide TabletscGMP deviations: Batch was released prior to approval.Aurobindo Pharma USA Inc. · D-1087-2023Class IIIOngoingAug 23, 2023Tobramycin Opthalmic Solution USPFailed Impurities/Degradation SpecificationsAlembic Pharmaceuticals, Inc. · D-1086-2023Class IIITerminatedAug 23, 2023PLUVICTO 1Labeling: Incorrect or Missing Lot and/or Exp Date: vials were labeled with the incorrect lot number and expiration dateAdvanced Accelerator Applications USA, Inc. · D-1085-2023Class IITerminatedAug 23, 2023hello wild strawberry fluoride toothpasteLabeling: Label Mix-Up: Some hello wild strawberry fluoride toothpaste, packaged in cartons labeled as hello wild strawberry fluoride toothpaste were incorrectly filled...Colgate Palmolive Company · D-1084-2023Class IIITerminatedAug 16, 20230.9% Sodium Chloride Injection USPLabeling: Not Elsewhere Classified - the description, warnings, storage information and instructions for use are either missing or partially printed.B. Braun Medical Inc. · D-1083-2023Class IIITerminatedAug 16, 2023Dofetilide Capsules 500 mcgOut of Specification result observed in content uniformity testingSun Pharmaceutical Industries Inc · D-1082-2023Class ITerminatedAug 9, 2023Tydemy (drospirenoneFailed Stability Specification and Failed Impurities/Degradation Specifications: out of specification for inactive content ascorbic acid and MTHFRC-7impurity testLupin Pharmaceuticals Inc. · D-1081-2023Class IITerminatedAug 9, 2023morphine in 0.9% Sodium ChlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1080-2023Class IITerminatedAug 9, 2023fentaNYL in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1079-2023Class IITerminatedAug 9, 2023PHENYLephrine in 0.9 sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1078-2023Class IITerminatedAug 9, 2023PHENYLephrine in 0.9 sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1077-2023Class IITerminatedAug 9, 2023rocuroniumLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1076-2023Class IITerminatedAug 9, 2023midazolam in dextrose 5%Lack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1075-2023Class IITerminatedAug 9, 2023lidocaine 2%Lack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1074-2023Class IITerminatedAug 9, 2023ePHEDrine in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1073-2023Class IITerminatedAug 9, 2023fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 250 mLLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1072-2023Class IITerminatedAug 9, 2023ketamine in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1071-2023Class IITerminatedAug 9, 2023fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1070-2023Class IITerminatedAug 9, 2023fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1069-2023Class IITerminatedAug 9, 2023morphine in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1068-2023Class IITerminatedAug 9, 2023fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1067-2023Class IITerminatedAug 9, 2023PHENYLephrine in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1066-2023Class IITerminatedAug 9, 2023morphine in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1065-2023Class IITerminatedAug 9, 2023morphine in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1064-2023Class IITerminatedAug 9, 2023fentaNYL in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1063-2023Class IITerminatedAug 9, 2023fentaNYL in 0.9% sodium chlorideLack of assurance of sterility: Lack of validation data for sanitization cyclesCentral Admixture Pharmacy Services Inc · D-1062-2023

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.